Download Files:
CDK9 inhibitor HH1
$72
Only 1000 item(s) left in stock.
Products Details
Product Description
– CDK9 inhibitor HH1 is a potent and selectively CDK9 inhibitor. CDK9 inhibitor HH1 inhibits the transcription of CDK. CDK9 inhibitor HH1 can be used in research of cancer[1].
Web ID
– HY-124639
Shipping
– Room temperature
Molecular Formula
– C13H15N3OS
References
– [1]Pandey S, et, al. Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells. Cancers (Basel). 2022 Jul 8;14(14):3340.
CAS Number
– 204188-41-0
Molecular Weight
– 261.34
SMILES
– O=C(C1=C(N)N=C(NC(C)C)S1)C2=CC=CC=C2
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– CDK
Isoform
– CDK9
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
